Pharmaceuticals & Therapeutics

A new technical report reveals an 85% IRR for the Arraias project, positioning Itafos to tap into Brazil's huge domestic fertilizer market.

A new German partnership aims to create variant-ready, room-temperature stable vaccines, moving beyond the limits of first-generation mRNA technology.

The deal marks the final step in a major strategic overhaul for dsm-firmenich, which will now focus solely on its nutrition, health, and beauty businesses.

A national scholarship founded by a top neurosurgeon invests in students poised to solve healthcare’s biggest challenges, addressing critical workforce shortages.

A new federal grant positions Curio's NuCycle technology to tackle nuclear waste, promising a cleaner, more sustainable American energy future.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.

South Korean firm Neurophet wins its third FDA clearance for an AI tool that precisely tracks Alzheimer's therapy side effects, eyeing U.S. expansion.

The CDMO giant's new independently validated system provides clients with auditable carbon data, raising the bar for sustainability in drug manufacturing.

A European company with Big Pharma roots brings its natural allergy aid, SnizIQ, to California, tapping into a growing demand for alternatives.

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

Fresh from its Honeywell spin-off, Solstice Advanced Materials' CEO will address investors amid a stock surge and big bets on AI, nuclear, and semis.

Employers are ditching fragmented vendors for unified platforms that promise to cut costs and complexity, fueling a surge in healthcare technology M&A.

With a massively oversubscribed bond sale and upgraded credit ratings, Italian API giant FIS solidifies its finances to expand in a booming pharma market.

TransCode Therapeutics and Quantum Leap are targeting hidden cancer cells with a novel RNA drug in a pivotal trial that could prevent colorectal cancer relapse.

A new partnership aims to overcome the hurdles of at-home testing by combining instrument-free PCR with advanced enzymes for rapid, reliable results.

With backing from top VCs, Angitia Biopharmaceuticals is accelerating its novel treatments for osteoporosis and rare bone disorders. Here's why it matters.

Insulet launches its tubeless Omnipod 5 insulin pump and new Discover data platform in the Middle East, offering a new lifeline for a region in need.

A new report reveals how GLP-1 drugs are accelerating a major healthcare shift in the Gulf, turning metabolic health into a core economic and policy issue.

The UK-based firm's STIMULAN® is now the only EU-certified calcium matrix for combined antibiotic use, revolutionizing bone infection treatment.